Work Here?
Overview
Healx uses artificial intelligence to discover and repurpose drugs for rare diseases. Its AI platform analyzes biomedical data to identify existing medicines that could treat rare conditions and speeds up the research and development process through collaborations with patient groups, research institutions, and pharmaceutical companies. The company then licenses or milestones its discoveries to partners, sharing royalties based on successful therapies. Unlike firms that build candidates in-house, Healx focuses on partnerships and drug repurposing to expand its pipeline and reduce time and cost of bringing treatments to patients. The overall goal is to bring safe and effective therapies to people with rare diseases more quickly and efficiently.
About Healx
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series C
Total Funding
$136.9M
Headquarters
Cambridge, United Kingdom
Founded
2014
People at Healx
People at Healx who can refer or advise you
Simplify's Take
What believers are saying
- FDA IND approval for HLX-0201 in Fragile X marks clinical-stage transition.
- Phase 2 INSPIRE-NF1 trial dosed for HLX-1502, with tumor response results expected soon.
- HealNet achieved 93% success rate and identified 50+ novel mechanisms of action.
What critics are saying
- Recursion Pharmaceuticals competes for NF1 and SCI targets, eroding milestone revenue in 9–15 months.
- Children's Tumor Foundation may halt HLX-1502 payments due to FDA IND delays, triggering liquidity crisis in 6–12 months.
- Amazon Health launches generative AI rare disease platform undercutting Healx pricing in 10–16 months.
What makes Healx unique
- Healx uses hypothesis-free HealNet AI to repurpose approved drugs for rare diseases.
- It partners with patient groups and pharma to advance clinical-stage rare disease programs.
- The company runs parallel drug discovery stages at scale, cutting time and cost.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$136.9M
Above
Industry Average
Funded Over
5 Rounds
Industry standards
Benefits
Health Insurance
Stock Options
Life Insurance
Remote Work Options
Flexible Work Hours
Hybrid Work Options
Home Office Stipend
Paid Vacation
Paid Holidays
Wellness Program
Professional Development Budget
Community Engagement and Support
Family Planning Benefits
Growth & Insights and Company News
6 month growth
↓ -4%1 year growth
↓ -4%2 year growth
↓ -1%Healx’s proprietary AI platform has uncovered and prioritised therapeutic opportunities across rare diseases and is actively applied in rare and pediatric oncology. The platform is designed to generate and advance Healx’s own discovery programs, making it a natural fit with Vuja De Sciences, which brings both deep expertise in metastatic recurrence and a clinical-stage programme … Continued
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, is proud to announce that world-renowned computational drug discovery expert, Nathan Brown, has joined the team as Director of Digital Chemistry.
Healx is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Healx
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series C
Total Funding
$136.9M
Headquarters
Cambridge, United Kingdom
Founded
2014
Healx is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today